Fluorescence lifetime imaging device for 5-ALA-guided neurosurgery
Fluorescence lifetime imaging device for 5-ALA-guided neurosurgery
批准号:
10698741
负责人:
Julien Bec
金额:
$23.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-06-01 至 2025-01-31
关键词:
AddressAdoptionAffectAminolevulinic AcidApplications GrantsAutomatic Data ProcessingBiomedical EngineeringBloodBrain NeoplasmsBreast-Conserving SurgeryCarcinomaCaringClinicalCollaborationsCommunity Clinical Oncology ProgramContrast MediaCustomDataDetectionDevelopmentDevicesEquipmentExcisionFluorescenceFrequenciesFundingGliomaHumanImageImaging DeviceIntuitionJudgmentLightLightingManufacturerMarketingMeasurementMedicalMedical DeviceMedical ImagingMicroscopeMissionMorbidity - disease rateNoiseNormal tissue morphologyOncologyOperating RoomsOperative Surgical ProceduresPatientsPerceptionPerformancePhasePhase III Clinical TrialsPhysiologic pulsePilot ProjectsPricePropertyQuality of lifeResearchResidual CancersResidual NeoplasmSamplingSchemeSideSignal TransductionSmall Business Innovation Research GrantSmall Business Technology Transfer ResearchSourceSpeedStructureSurfaceSurgeonSurgical InstrumentsSurgical OncologySystemTechniquesTechnologyTimeTissuesTranslatingTumor TissueUnited States National Institutes of HealthValidationVisualVisualizationWorkanalogbrain tumor resectionclinical practicecommercializationcomputerized data processingcostdata acquisitiondetection sensitivitydigitalfluorescence lifetime imagingfluorescence-guided surgeryfluorophoreimaging agentimaging systemimprovedin vivoinstrumentationintraoperative optical imagingmembernanosecondneoplastic cellneurosurgeryoperationprocessing speedprotoporphyrin IXratiometrictumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
5-ALA-induced PpIX fluorescence-guided surgery (FGS) enables real-time visualization of residual cancer tissue
during resection of brain tumors. This addresses a critical need in surgical oncology as the ability to identify
residual tumor leads to improvements in overall survival, whereas the sparing of normal tissue benefits the
patient’s quality of life. Currently, surgeons visually appreciate the PpIX fluorescence intensity under low-light
conditions using modified microscopes. This approach is qualitative as the perception of PpIX fluorescence
intensity is influenced by many factors including: 1) the type of light source used for illumination, 2) the
microscope’s working distance, 3) the presence of endogenous absorbers such as blood, and 4) non-uniform
illumination of the surgical field which is especially critical as residual tumor present on the sides of the surgical
cavity may be missed due to insufficient fluorescence excitation. Additionally, operation under low-light
conditions disrupts the surgical workflow.
Our research group at UC Davis has developed a fluorescence lifetime (FLIm) based FGS approach that is
highly sensitive, quantitative, and insensitive to room light, addressing the challenges of the existing 5-ALA FGS
instrumentation. The performances of this system were evaluated in a recent pilot study demonstrating 5-ALA-
induced PpIX fluorescence detection in human high- and low-grade glioma patients in vivo (patients during
surgery).
Building on these results, HiLight Surgical was established by team members from UC Davis with the mission
to support surgeons by developing and commercializing easy-to-use imaging systems that provide accurate,
quantitative information about fluorophore accumulation, at a price point suitable for broad adoption by the
surgical oncology community. We plan to develop and validate a low-cost, high performance FLIm FGS system
in this phase I proposal by:
SA1: Implementing FLIm data acquisition and processing using a low-cost high-speed analog-to-
digital converter (ADC) and an FPGA. This will enable a ~4-fold cost reduction of the system as well as reduce
its footprint.
SA2: Characterize the performance of this alternative data acquisition and processing
implementation compared to the reference research-grade instrumentation.
At the conclusion of this work, we will have determined whether the performance achieved with this
alternative low-cost data acquisition and processing is suitable to proceed with the development of a commercial
FLIm device well-tailored for the requirements of 5-ALA fluorescence-guided surgery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金